Candel Therapeutics, Inc. (CADL)

11.19 +0.17 (+1.54%) USD  |  NASDAQ  |  Sep 28, 16:00
11.19 0.00 (0.00%) After-Hours: 19:25
More

Candel Therapeutics Cash and Short Term Investments (Quarterly) : 201.56M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for CADL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 201.56M
March 31, 2026 194.83M
December 31, 2025 119.73M
September 30, 2025 86.96M
June 30, 2025 100.69M
March 31, 2025 92.16M
December 31, 2024 102.65M
September 30, 2024 16.56M
June 30, 2024 21.45M
March 31, 2024 25.71M
December 31, 2023 35.41M
September 30, 2023 42.98M
Date Value
June 30, 2023 51.89M
March 31, 2023 59.26M
December 31, 2022 70.06M
September 30, 2022 77.18M
June 30, 2022 86.78M
March 31, 2022 94.32M
December 31, 2021 82.64M
September 30, 2021 88.38M
June 30, 2021 24.32M
March 31, 2021 29.15M
December 31, 2020 35.05M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Arcturus Therapeutics Holdings, Inc. 191.48M
ACADIA Pharmaceuticals, Inc. 956.47M
Alnylam Pharmaceuticals, Inc. 3.308B
Anika Therapeutics, Inc. 38.41M
Savara, Inc. 173.03M